课题基金 / 基金详情

Regulation of systemic inflammatory response syndrome by TNF-related apoptosis inducing ligand which affect neutrophils exclusion and its potential clinical application.

Regulation of systemic inflammatory response syndrome by TNF-related apoptosis inducing ligand which affect neutrophils exclusion and its potential clinical application.
TNF相关凋亡诱导配体影响中性粒细胞排除的全身炎症反应综合征的调节及其潜在的临床应用。
批准号:
23591870
负责人:
KAMOHARA hidenobu
金额:
$3.33万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
我们已经鉴定了中性粒细胞表达TRAIL和TRAIL-R,其由IFN γ诱导并由TNF α降低。最后,TNF α诱导中性粒细胞凋亡,IFN γ减少。在本研究中,白细胞分离外周血和局部渗出液从术后引流SIRS。与外周血白细胞相比,渗出液白细胞中TRAIL、TRAIL-R1和-R2(死亡受体)mRNA水平显著升高,TRAIL-R3和-R4(诱饵受体)mRNA水平显著降低。TNF α或IFN γ上调或下调TRAIL受体表达可影响中性粒细胞对TRAIL的敏感性。在局部炎症区,中性粒细胞被大量细胞因子激活,表达TRAIL、-R1和-R2的中性粒细胞可转变为凋亡细胞。TRAIL信号通路可能调节SIRS时组织浸润中性粒细胞的命运。
英文摘要
We have been identified that neutrophils express TRAIL and TRAIL-R which were induced by IFNgamma and reduced by TNFalpha. Finally, TNFalpha induced the netrophils apoptosis and IFNgamma reduced. In the present study, leukocytes were isolated in peripheral blood and local exudates from post-operative drain in SIRS. The level of TRAIL, TRAIL-R1, and -R2 (death receptor) mRNA were significant higher and the level of TRAIL-R3 and -R4 (decoy receptor) mRNA were significant lower in leukocytes from exudates than leukocytes form peripheral blood. Up- or down-regulation of TRAIL receptor expression by TNFalpha or IFNgamma can affect the susceptibility of neutrophils to TRAIL. In local inflammatory field, neutophils are activated by high amount of cytokines and neutophils expressing TRAIL, -R1 and -R2 can transit to be apoptosis. TRAIL signaling pathway could potentially regulate the fate of tissue-infiltrating neutrophils during SIRS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/jso.23064
发表时间: 2012-08-01
期刊: JOURNAL OF SURGICAL ONCOLOGY
影响因子: 2.5
作者: [Kurashige, Junji, Kamohara, Hidenobu, Baba, Hideo]
通讯作者: Baba, Hideo
国内基金
海外基金
miRNA-490-3p调控TRAIL在胎盘植入性疾病中的机制研究
细胞外囊泡装载 TRAIL 和小核酸 siRNA 用于肺癌靶向治疗
  • 批准号:
    2024JJ7531
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    胡小毛
  • 依托单位:
非典型趋化因子受体1阳性内皮细胞通过TRAIL-DR5调节BMSC成骨成脂分化及其机制
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    赵亮
  • 依托单位:
聚多巴胺纳米颗粒负载青藤碱通过ROCK2/TRAIL 通路增强 NK 细胞对胃癌的杀伤